Focused pseudostatic hydrazone libraries screened by mass spectrometry binding assay: Optimizing affinities toward γ-aminobutyric acid transporter 1

Journal of Medicinal Chemistry

Volumn 56, Issue 3, 2013, Pages 1323-1340

  Sindelar, Miriam ^a   Lutz, Toni A ^a   Petrera, Marilena ^a,b   Wanner, Klaus T ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2',4' DICHLOROBIPHENYL DERIVATIVE; 4 AMINOBUTYRIC ACID; BIPHENYL; GAMMA AMINOBUTYRIC ACID TRANSPORTER 1; HYDRAZONE DERIVATIVE; NIPECOTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; MASS SPECTROMETRY;

GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HYDRAZONES; MASS SPECTROMETRY;

EID: 84873888803     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301800j     Document Type: Article

References (52)

1. Bowery, N. G.; Smart, T. G. GABA and glycine as neurotransmitters: a brief history Br. J. Pharmacol. 2006, 147, S109-S119
2. Beleboni, R. O.; Carolino, R. O. G.; Pizzo, A. B.; Castellan-Baldan, L.; Coutinho-Netto, J.; dos Santos, W. F.; Coimbra, N. C. Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships Cell. Mol. Neurobiol. 2004, 24, 707-728
3. Owens, D. F.; Kriegstein, A. R. Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 2002, 3, 715-727
4. Geffen, Y.; Nudelman, A.; Gil-Ad, I.; Raphaeli, A.; Huang, M.; Savitsky, K.; Klapper, L.; Winkler, I.; Meltzer, H. Y.; Weizman, A. BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy is efficacious in a rat model of schizophrenia Eur. Neuropsychopharmacol. 2009, 19, 1-13
5. Ishiwari, K.; Mingot, S.; Correa, M.; Trevitt, J. T.; Carlson, B. B.; Salamone, J. D. The GABA uptake inhibitor β-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis J. Neurosci. Methods 2004, 140, 39-46
6. Treiman, D. M. GABAergic mechanisms in epilepsy Epilepsia 2001, 42 (Suppl. 3) 8
7. Aoyagi, T.; Wada, T.; Nagai, M.; Kojima, F.; Harada, S.; Takeuchi, T.; Takahashi, H.; Hirokawa, K.; Tsumita, T. Increased γ-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease Chem. Pharm. Bull. 1990, 38, 1748-1749
8. Daemen, M. A. R. C.; Hoogland, G.; Cijintje, J.-M.; Spincemaille, G. H. Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy Neurosci. Lett. 2008, 444, 112-115
9. Zádori, D.; Geisz, A.; Vámos, E.; Vécsei, P. K. Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease Pharmacol., Biochem. Behav. 2009, 94, 148-153
10. Gajcy, K.; Lochynski, S.; Librowski, T. A role of GABA analogues in the treatment of neurological diseases Curr. Med. Chem. 2010, 17, 2338-2347
11. B receptors Drugs Today 2005, 41, 755-766
12. Krystal, J. H.; Sanacora, G.; Blumberg, H.; Anand, A.; Charney, D. S.; Marek, G.; Epperson, C. N.; Goddard, A.; Mason, G. F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments Mol. Psychiatry 2002, 7, S71-S80
13. Kirstensen, A. S.; Andersen, J.; Jørgensen, T. N.; Sørensen, J. E.; Loland, C. J.; Strømgaard, K.; Gether, U. SLC6 neurotransmitter transporters: structure, function, and regulation Pharmacol. Rev. 2011, 63, 585-640
14. Madsen, K. K.; Rasmus, P. C.; Larsson, O. M.; Krogsgaard-Larsen, P.; Schousboe, A.; White, H. S. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs J. Neurochem. 2009, 109, 139-144
15. Palacín, M.; Estévez, R.; Bertran, J.; Zorzano, A. Molecular biology of mammalian plasma membrane amino acid transporters Physiol. Rev. 1998, 78, 969-1054
16. Zhou, Y.; Holmseth, S.; Guo, C.; Hassel, B.; Höfner, G.; Hitfeldt, H. S.; Wanner, K. T.; Danbolt, N. C. Deletion of the γ-aminobutyric acid transporter 2 (GAT2 and SLC6A13) gene in mice leads to changes in liver and brain taurine contents J. Biol. Chem. 2012, 287, 35733-35746
17. Zhou, Y.; Holmseth, S.; Hua, R.; Lehre, A. C.; Olofsson, A. M.; Poblete-Naredo, I.; Kempson, A. A.; Danbolt, N. C. The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface Am. J. Physiol.: Renal Physiol. 2012, 304, F316-F328
18. Lehre, A. C.; Rowley, N. M.; Zhou, Y.; Homseth, S.; Guo, C.; Holen, T.; Hua, R.; Laake, P.; Olfsson, A. M.; Poblete-Naredo, I.; Rusakov, D. A.; Madsen, K. K.; Clausen, R. P.; Schousboe, A.; White, H. S.; Danbolt, N. C. Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure threshold of adult mice Epilepsy Res. 2011, 95, 75-81
19. 3H]GABA by slices of rat cerebral cortex J. Neurochem. 1968, 15, 1141-1149
20. Iversen, L. L.; Johnston, G. A. R. GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors J. Neurochem. 1971, 18, 1939-1950
21. Krogsgaard-Larsen, P.; Johnston, G. A. R. Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds J. Neurochem. 1975, 25, 797-802
22. Krogsgaard-Larsen, P.; Falch, E.; Larsson, O. M.; Schousboe, A. GABA uptake inhibitors: relevance to antiepileptic drug research Epilepsy Res. 1987, 1, 77-93
23. Frey, H.-H.; Popp, C.; Loescher, W. Influence of the inhibitors of high affinity GABA uptake on seizure threshold in mice Neuropharmacology 1979, 18, 581-590
24. Ali, F. E.; Bondinell, W. E.; Dandridge, P. A.; Frazee, J. S.; Garvey, E.; Girard, G. R.; Kaiser, C.; Ku, T. W.; Lafferty, J. J.; Moonsammy, G. I.; Oh, H.-J.; Rush, J. A.; Setler, P. E.; Stringer, O. D.; Venslavsky, J. W.; Volpe, B. W.; Yunger, L. M.; Zirkle, C. L. Orally active and potent inhibitors of γ-aminobutyric acid uptake J. Med. Chem. 1985, 28, 653-660
25. Dalby, N. O. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors Neuropharmacology 2000, 39, 2399-2407
26. Borden, L. A.; Dhar, T. G. M.; Smith, K. E.; Weinshank, R. L.; Branchek, T. A.; Gluchowski, C. Tiagabine, SK& F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1 Eur. J. Pharmacol. 1994, 269, 219-224
27. Andersen, K. E.; Sørensen, J. L.; Huusfeldt, P. O.; Knutsen, L. J. S.; Lau, J.; Lundt, B. F.; Petersen, H.; Suzdak, P. D.; Swedberg, D. B. Synthesis of novel GABA uptake inhibitors. 4.1 Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates J. Med. Chem. 1999, 42, 4281-4291
28. Andersen, K. E.; Lau, J.; Lundt, B. F.; Petersen, H.; Huusfeldt, P. O.; Suzdak, P. D.; Swedberg, D. B. Synthesis of novel GABA uptake inhibitors. Part 6: Preparation and evaluation of N-Ω asymmetrically substituted nipecotic acid derivatives Bioorg. Med. Chem. 2001, 9, 2773-2785
29. Zepperitz, C.; Höfner, G.; Wanner, K. T. MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1 ChemMedChem 2006, 1, 208-217
30. Höfner, G.; Wanner, K. T. Competitive binding assays made easy with a native marker and mass spectrometric quantification Angew. Chem., Int. Ed. 2003, 42, 5235-5237
31. Höfner, G.; Zepperitz, C.; Wanner, K. T. MS Binding Assays. An Alternative to Radioligand Binding. In Mass Spectrometry in Medicinal Chemistry, 1 st ed.; Wanner, K. T.; Höfner, G., Eds.; Wiley, VCH: Weinheim, Germany, 2007; pp 247-283.
32. Sindelar, M.; Wanner, K. T. Library screening by means of mass spectrometry (MS) binding assays-exemplarily demonstrated for a pseudostatic library addressing γ-aminobutyric acid (GABA) transporter 1 (GAT1) ChemMedChem 2012, 7, 1678-1690
33. Bucci, M. Methods: how to get GAT Nat. Chem. Biol. 2012, 8, 678
34. Kalia, J.; Raines, R. T. Hydrolytic stability of hydrazones and oximes Angew. Chem. 2008, 47, 7523-7526
35. Scharer, L.; Smith, J. P. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid Ann. Intern. Med. 1969, 1113-1120
36. Huq, F. Molecular modeling analysis of the metabolism of isoniazid J. Pharmacol. Toxicol. 2006, 1, 447-455
37. Tafazoli, S.; Mashregi, M.; O'Brien, P. The role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model J. Toxicol. Appl. Pharmacol. 2008, 229, 94-101
38. Busch, M.; Dietz, W. Autoxydation der hydrazone Ber. Dtsch.. Chem. Ges. 1914, 47, 3277-3291
39. Harej, M.; Dolec, D. Autoxidation of hydrazones. Some new insights J. Org. Chem. 2007, 72, 7214-7221
40. Yao, H. C.; Resnick, P. Azo-hydrazone conversion: the autoxydation of benzaldehyde phenylhydrazones J. Org. Chem. 1965, 30, 2832-2834
41. Miyaura, N.; Yanagi, T.; Suzuki, A. The palladium-catalyzed cross-coupling reaction of phenylboronic acid with haloarenes in the presence of bases Chem. Commun. 1981, 11, 513-519
42. Andrews, M. D.; Brown, A. D.; Fish, P. V.; Fray, M. J.; Lansdell, M. I.; Ryckmans, T.; Stobie, A.; Vakenhut, F.; Gray, D.; La, F. Preparation of N -(Pyrrolidin-3-yl) Carboxamide Derivatives as Serotonin and Noradrenalin Re-Uptake Inhibitors. PCT Int. Appl. WO 2006064351 A2 20060622, 2006.
43. Kistensen, J.; Lysén, M.; Vedsø, P.; Begrup, M. Synthesis of ortho substituted arylboronic esters by in situ trapping of unstable lithio intermediates Org. Lett. 2001, 3, 1435-1437
44. Zhao, J.; Yue, D.; Campo, M. A.; Larock, R. C. An aryl to imidoyl palladium migration process involving intramolecular C-H activation J. Am. Chem. Soc. 2007, 129, 5288-5295
45. Korenaga, T.; Kosaki, T.; Fukumura, R.; Ema, T.; Sakai, T. Suzuki-Miyaura coupling reaction using pentafluorophenylboronic acid Org. Lett. 2005, 7, 4915-4917
46. Irngartinger, H.; Escher, T. Strong electron acceptor properties of 3′-(pentafluorophenyl)isoxazolol[4′,5′:1,2][60]fullerene derivatives Tetrahedron 1999, 55, 10753-10760
47. Zammit, S. C.; Cox, A. J.; Gow, R. M.; Zhang, Y.; Gilbert, R. E.; Krum, H.; Kelly, D. J; Williams, S. J. Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates Bioorg. Med. Chem. Lett. 2009, 19, 7003-7006
48. Wang, Y. D.; Kimball, G.; Prashad, A. S.; Wang, Y. Zr-mediated hydroboration: stereoselective synthesis of vinyl boronic esters Tetrahedron Lett. 2005, 46, 8777-8780
49. Braestrup, C.; Nielsen, E. B.; Sonnewald, U.; Knutsen, L. J. S.; Andersen, K. E.; Jansen, J. A.; Frederiksen, P. H. A.; Mortensen, A.; Suzdak, P. D. (R)- N -[4,4-Bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain γ-aminobutyric acid uptake carrier J. Neurochem. 1990, 639-647
50. Kragler, A.; Höfner, G.; Wanner, K. T. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-GAT4 Eur. J. Med. Chem. 2008, 43, 2404-2411
51. Zepperitz, C.; Höfner, G.; Wanner, K. T. Expanding the scope of MS binding assays to low-affinity markers as exemplified for mGAT1 Anal. Bioanal. Chem. 2008, 391, 309-316
52. 50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108